Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Potassium chloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for potassium chloride and what is the scope of potassium chloride patent protection?

Potassium chloride
is the generic ingredient in thirty-nine branded drugs marketed by Fresenius Kabi Usa, Lupin Ltd, Baxter Hlthcare, Abraxis Pharm, Actavis Labs Fl Inc, Hospira, Upsher-smith Labs, Watson Labs, Kremers Urban Pharms, Lehigh Valley, Copley Pharm, Pharma Res Software, Gd Searle Llc, Luitpold, Upsher Smith Labs, Savage Labs, Amneal Pharms, Novel Labs Inc, Sigmapharm Labs Llc, Teva, Nesher Pharms, Schering, Tris Pharma Inc, Pharmaceutics Intl, Apothecon, Kv Pharm, Icu Medcl, Pharma Serve Ny, Glenmark Pharms Ltd, Mylan Pharms Inc, Intl Medication, Adare Pharms Inc, Lilly, B Braun, Novartis, Abbvie, Paddock Llc, Anchen Pharms, Akorn, Miles, and Future Pak, and is included in eighty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two hundred and twenty-seven drug master file entries for potassium chloride. Seventy-four suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: potassium chloride

Drug Master File Entries: see list227
Suppliers / Packagers: see list74
Bulk Api Vendors: see list127
Clinical Trials: see list406
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:potassium chloride at DailyMed

Pharmacology for Ingredient: potassium chloride

Tentative approvals for POTASSIUM CHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe20MEQTablet; Oral
► Subscribe► Subscribe10MEQTablet, Extended Release; Oral
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
potassium chloride; sodium chloride; tromethamine
INJECTABLE;INJECTION013025-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Tris Pharma Inc
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL201944-001Mar 4, 2016ABRXNoNo► Subscribe► Subscribe
potassium chloride
TABLET, EXTENDED RELEASE;ORAL019381-001Apr 16, 1986DISCNNoNo► Subscribe► Subscribe
Adare Pharms Inc
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL208864-001Mar 17, 2017ABRXNoNo► Subscribe► Subscribe
potassium chloride
TABLET, EXTENDED RELEASE;ORAL018279-003Nov 25, 2013BCRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus